Viking Therapeutics (NASDAQ:VKTX) Price Target Lowered to $70.00 at Maxim Group
Viking Therapeutics (NASDAQ:VKTX – Free Report) had its target price lowered by Maxim Group from $120.00 to $70.00 in a research note issued to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the biotechnology company’s stock. A number of other analysts have also recently commented on the stock. HC Wainwright […]
Viking Therapeutics (NASDAQ:VKTX – Free Report) had its target price lowered by Maxim Group from $120.00 to $70.00 in a research note issued to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the biotechnology company’s stock. A number of other analysts have also recently commented on the stock. HC Wainwright […]
